Metraipolis › archive › dc_9371bda44bfa
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major adverse kidney events in diabetic people with varied kidney function decline — Europe PMC PMID:41625233
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41625233
- DOI
- 10.3389/fendo.2025.1647342
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T19:02:14.197Z
- SHA-256 of the archived text
64291eb0843652fb0c19ed922fd9b5bc657dcca18f16df9e08266d841146aaf8- Stable URL of this page
https://metraipolis.com/documento/dc_9371bda44bfa
How to cite
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major adverse kidney events in diabetic people with varied kidney function decline — Europe PMC PMID:41625233 — Europe PMC (en), https://europepmc.org/article/MED/41625233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9371bda44bfa (Metraipolis archive dc_9371bda44bfa, sha256 64291eb0843652fb0c19ed922fd9b5bc657dcca18f16df9e08266d841146aaf8)
BibTeX
@misc{dc9371bda44bfa,
title = {Effect of SGLT2 inhibitors versus DPP4 inhibitors on major adverse kidney events in diabetic people with varied kidney function decline — Europe PMC PMID:41625233},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41625233},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9371bda44bfa; sha256 64291eb0843652fb0c19ed922fd9b5bc657dcca18f16df9e08266d841146aaf8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41625233. Agents can read the archived copy with the MCP tool read_document.